![]()
|
|
||||||||
(Received for publication, October 9, 1996, and in revised form, December 2, 1996)
From the Department of Haematology, University of Cambridge,
Medical Research Council Centre, Hills Road, Cambridge CB2 2QH,
United Kingdom
The reactive-site loops of serpins are
characterized by a defined mobility where the loop adopts a new
secondary structure as an essential part of the inhibitory process.
While the importance of mobility in the N-terminal region of the
reactive-site loop has been well studied, the role of mobility in the
C-terminal portion has not been investigated. The requirements for
mobility of the C-terminal portion of the reactive-site loop of
Volume 272, Number 7,
Issue of February 14, 1997
pp. 3905-3909
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
MOBILITY OF THE C-TERMINAL REGION OF THE REACTIVE-SITE LOOP
1-antitrypsin were investigated by creating a
disulfide bridge between the P
3 residue and residue 283 near the top of strand 2C; this disulfide would restrict the mobility
of the C-terminal portion of the reactive-site loop by locking together
strands 1 and 2 of the C
-sheet. The engineered disulfide bond had
no effect on the inhibitory activity of
1-antitrypsin,
indicating that there is no requirement for mobility in this region of
the molecule. Moreover, these results, coupled with those from
molecular modeling, indicate that insertion into the A
-sheet of the
intact reactive-loop beyond P12 is not rate-limiting for
the formation of the stable complex. The engineered disulfide bond
should also prove useful in the creation of more stable serpin
variants; for example, such a bond in plasminogen activator inhibitor-1
would prevent it from becoming latent by locking strand 1C onto the C
-sheet.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
H. Parfrey, R. Mahadeva, N. A. Ravenhill, A. Zhou, T. R. Dafforn, R. C. Foreman, and D. A. Lomas Targeting a Surface Cavity of {alpha}1-Antitrypsin to Prevent Conformational Disease J. Biol. Chem., August 29, 2003; 278(35): 33060 - 33066. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. De Taeye, G. Compernolle, M. Dewilde, W. Biesemans, and P. J. Declerck Immobilization of the Distal Hinge in the Labile Serpin Plasminogen Activator Inhibitor 1: IDENTIFICATION OF A TRANSITION STATE WITH DISTINCT CONFORMATIONAL AND FUNCTIONAL PROPERTIES J. Biol. Chem., June 20, 2003; 278(26): 23899 - 23905. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Shin and M.-H. Yu Kinetic Dissection of alpha 1-Antitrypsin Inhibition Mechanism J. Biol. Chem., March 29, 2002; 277(14): 11629 - 11635. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Bottomley, I. D. Lawrenson, D. Tew, W. Dai, J. C. Whisstock, and R. N. Pike The role of strand 1 of the C {beta}-sheet in the structure and function of {alpha}1-antitrypsin Protein Sci., December 1, 2001; 10(12): 2518 - 2524. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Bauman and F. C. Church Enhancement of Heparin Cofactor II Anticoagulant Activity J. Biol. Chem., December 3, 1999; 274(49): 34556 - 34565. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. James, J. C. Whisstock, M. G. Gore, and S. P. Bottomley Probing the Unfolding Pathway of alpha 1-Antitrypsin J. Biol. Chem., April 2, 1999; 274(14): 9482 - 9488. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Picard, P.-E. Marque, F. Paolucci, M. Aiach, and B. F. Le Bonniec Topology of the Stable Serpin-Protease Complexes Revealed by an Autoantibody That Fails to React with the Monomeric Conformers of Antithrombin J. Biol. Chem., February 19, 1999; 274(8): 4586 - 4593. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |